CUE HEALTH INC

CUE HEALTH INC

OOTC:HLTHQ
0.00
USD
0.00
(0.00%)
-2.44EPS
25.24MMarket Cap

Total Valuation

USD

As of December 31, 2023, CUE HEALTH INC carries a market capitalization of 25.24M, placing it among publicly traded companies globally. Its enterprise value stands at -7.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap25.24M
Enterprise Value-7.71M

Important Dates

CUE HEALTH INC's next confirmed earnings release is scheduled for November 16, 2026.

Earnings Date11/16/2026

Share Statistics

As of December 31, 2023, CUE HEALTH INC has 155.30M shares outstanding.

Shares Outstanding155.30M

Valuation Ratios

These figures are as of December 31, 2023. The price-to-sales ratio is 0.39, and the price-to-book ratio stands at 0.10.

PS Ratio0.39
PB Ratio0.10
P/TBV Ratio0.11
P/FCF Ratio-0.17
P/OCF Ratio-0.18

Financial Position

As of December 31, 2023, CUE HEALTH INC maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.16, indicating elevated leverage, while an interest coverage ratio of -292.13 demonstrates limited ability to service its debt obligations.

Current Ratio2.54
Quick Ratio1.89
Debt / Equity19.16
Debt / EBITDA-0.14
Interest Coverage-292.13

Financial Efficiency

USD

Over the twelve months ended December 31, 2023, CUE HEALTH INC posted a negative return on equity (ROE) of -90.35, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -72.21, reflecting losses generated across the asset base. The company generates approximately 48,736.86 in revenue per employee across its workforce of 1,317.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.64 indicates how many times CUE HEALTH INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-90.35
Return on Assets (ROA)-72.21
Revenue Per Employee48,736.86
Employee Count1,317.75
Inventory Turnover2.64

Taxes

USD

Over the twelve months ended December 31, 2023, CUE HEALTH INC recorded 4.79M in income tax expense. The company reported a pretax loss of -368.67M and -373.46M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax4.79M

Income Statement

USD

Over the twelve months ended December 31, 2023, CUE HEALTH INC generated 64.22M in revenue and converted that into -373.46M in net income, yielding earnings per share of -2.44. EBITDA reached -338.57M, while operating income came in at -275.77M.

Revenue64.22M
Gross Profit-62.87M
Operating Income-275.77M
Pretax Income-368.67M
Net Income-373.46M
EBITDA-338.57M
EBIT-394.85M
Earnings Per Share (EPS)-2.44

Balance Sheet

USD

As of December 31, 2023, CUE HEALTH INC holds 80.89M in cash and equivalents against 47.94M in total debt, resulting in a net debt position of -80.89M. Total book value stands at 250.25M, with working capital of 66.90M providing operational flexibility.

Cash & Cash Equivalents80.89M
Total Debt47.94M
Net Debt-80.89M
Equity (Book Value)250.25M
Book Value Per Share1.61
Working Capital66.90M

Cash Flow

USD

CUE HEALTH INC produced -137.81M in operating cash flow over the twelve months ended December 31, 2023. After subtracting -9.17M in capital expenditures, free cash flow totaled -146.98M - equivalent to -0.96 per share.

Operating Cash Flow-137.81M
Capital Expenditures-9.17M
Free Cash Flow-146.98M
FCF Per Share-0.96

Margins

Over the twelve months ended December 31, 2023, CUE HEALTH INC posted a gross margin of -97.89, reflecting its pricing power and cost economics. The operating margin of -429.40 and net profit margin of -581.51 provide insight into operational efficiency.

Gross Margin-97.89
Operating Margin-429.40
Pretax Margin-574.05
Profit Margin-581.51
EBITDA Margin-527.19

Dividends & Yields

These figures cover the twelve months ended December 31, 2023. Free cash flow yield is negative at -591.69: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 12.01, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to CUE HEALTH INC shareholders.

Shareholder Yield12.01
FCF Yield-591.69

Scores

As of December 31, 2023, CUE HEALTH INC has an Altman Z-Score of -4.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-4.81